Sg Americas Securities, LLC Next Cure, Inc. Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$5.7 - $9.1 $270,778 - $432,295	-47,505 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$6.74 - $8.02 $704,720 - $838,555	-104,558 Reduced 68.76%	47,505 $320,000
Q2 2021 Aug 12, 2021	SELL	$7.6 - $10.28 $1.28 Million - $1.73 Million	-167,876 Reduced 52.47%	152,063 $1.22 Million
Q1 2021 May 13, 2021	BUY	$9.81 - $13.88 $3.14 Million - $4.44 Million	319,939 New	319,939 $3.2 Million
Q3 2020 Nov 09, 2020	SELL	$8.15 - $21.17 $275,665 - $716,054	-33,824 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$21.19 - $40.2 $644,557 - $1.22 Million	30,418 Added 893.07%	33,824 $725,000
Q1 2020 Apr 30, 2020	BUY	$32.32 - $58.37 $110,081 - $198,808	3,406 New	3,406 $126,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.